Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Dizziness, Fatigue, Lymphadenopathy, Migraine
Clinical narrative: Arm pain at injection site; swollen lymph nodes in neck, and right armpit; deep pain in right armpit; muscle aches in neck and shoulders; migraine; dizziness/lightheadedness; nausea; vertigo; fatigue; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 18Apr2021 11:30 (Batch/Lot number: EW0172) at the age of 44 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hypothyroid" (unspecified if ongoing); "Migraines" (unspecified if ongoing); "Bactrim allergy" (unspecified if ongoing); "Penicillin allergy" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID; VITAMIN D3. Vaccination history included: Bnt162b2 (product: COVID 19 brand: Pfizer, lot number: ER8727, lot unknown: False, administration time: 11:00 AM, dose number: 1, vaccine location: Right arm, adverse event start date: 28Mar2021), administration date: 28Mar2021, when the patient was 44 years old, for Covid-19 immunization, reaction(s): "Arm discomfort". The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 18Apr2021 18:00, outcome "not recovered", described as "Arm pain at injection site"; LYMPHADENOPATHY (non-serious) with onset 18Apr2021 18:00, outcome "not recovered", described as "swollen lymph nodes in neck, and right armpit"; AXILLARY PAIN (non-serious) with onset 18Apr2021 18:00, outcome "not recovered", described as "deep pain in right armpit"; MYALGIA (non-serious) with onset 18Apr2021 18:00, outcome "not recovered", described as "muscle aches in neck and shoulders"; MIGRAINE (non-serious) with onset 18Apr2021 18:00, outcome "not recovered", described as "migraine"; DIZZINESS (non-serious) with onset 18Apr2021 18:00, outcome "not recovered", described as "dizziness/lightheadedness"; NAUSEA (non-serious) with onset 18Apr2021 18:00, outcome "not recovered", described as "nausea"; VERTIGO (non-serious) with onset 18Apr2021 18:00, outcome "not recovered", described as "vertigo"; FATIGUE (non-serious) with onset 18Apr2021 18:00, outcome "not recovered", described as "fatigue". The event "arm pain at injection site" was evaluated at the physician office visit. Therapeutic measures were taken as a result of vaccination site pain, lymphadenopathy, axillary pain, myalgia, migraine, dizziness, nausea, vertigo, fatigue.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient was not tested for COVID post vaccination. Since the vaccination, the was not tested. for COVID-19. Patient received treatment for the adverse event with Antibiotic, vestibular physical therapy. Patient received vaccine at facility type vaccine: Pharmacy or Drug Store. Other medications in two weeks include, Multivitamin  No follow-up attempts are possible. No further information is expected.